Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model. Chem Biol Drug
Lange TS, Zou Y, Singh RK, Kim KK, Kristjansdottir K, Sholler GL, Brard L. Chemotherapeutic effect of calcidiol derivative B3CD in a neuroblastoma xenograft model. Chem Biol Drug Des. 2010 Aug;76(2):164-73. doi: 10.1111/j.1747-0285.2010.00988.x.[...]
Bortezomib and HDAC inhibitor PCI-24781 combination therapy for Neuroblastoma
Currier E, Illenye S, Ashikaga T, Lescault P, Bond J and Saulnier Sholler G. Bortezomib and HDAC inhibitor PCI-24781 combination therapy for Neuroblastoma. April 2010 AACR Annual Meeting, Washington DC
Neuroblastoma: a spectrum of cells isolated from bone marrow of patients
Saulnier Sholler G, Illenye S, Warzynski M, Brown RE, Lescault PJ, Koto K, Dorf L, Bond J. Neuroblastoma: a spectrum of cells isolated from bone marrow of patients. May 2009 ASCO Annual[...]
Increased cytotoxicity with nifurtimox and rapamycin combination therapy in neuroblastoma
Dorf L, Brard L, Koto K, Illenye S, Ashikaga T, Singh R, Kim K, Saulnier Sholler G. Increased cytotoxicity with nifurtimox and rapamycin combination therapy in neuroblastoma. April 2009, AACR Annual Meeting, Denver,[...]
Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo
Saulnier Sholler G, Brard L, Straub J, Dorf L, Illyene S, Kalkunte S, Nishi R. Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo. JPHO, 2009 Mar;31(3):187-93.
Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells
Brard L, Singh RK, Kim KK, Lange TS, Saulnier Sholler G Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells. Drug Des[...]
RKS-2-62: A Novel Therapy for Medulloblastoma with activity in vitro and in vivo
Koto K, Brard L, Bosenberg M, Dorf L, Illenye S, Singh R, Kim K, Saulnier Sholler G. RKS-2-62: A Novel Therapy for Medulloblastoma with activity in vitro and in vivo. June 2008 ISPNO Annual Meeting,[...]
A Phase I study of nifurtimox in patients with relapsed/refractory neuroblastoma
Saulnier Sholler G, Ferguson W, Brard L, Johnson G, Heath B, Bingham P, Ashikaga T, Kamen B, Homans A. A Phase I study of nifurtimox in patients with relapsed/refractory neuroblastoma. June[...]
A Novel Drug RKS-2-62 Is Cytotoxic To Neuroblastoma In Vitro And In Vivo
Dorf L, Brard L, Koto K, Bosenberg M, Illyene S, Singh R, Kim K, Saulnier Sholler G. A Novel Drug RKS-2-62 Is Cytotoxic To Neuroblastoma In Vitro And In Vivo. May 2008 ANR Meeting,[...]
Antitumor activity of Nifurtimox and MT-19C alone and in combination in medulloblastoma in vitro and in vivo
Koto K, Brard L, Bosenberg M, Dorf L, Illenye S, Singh R, Kim K, Saulnier Sholler G. Antitumor activity of Nifurtimox and MT-19C alone and in combination in medulloblastoma in vitro[...]